Abstract
The aim of this study was to determine whether procaine penicillin could be used in the treatment of suspected pneumococcal pneumonia of mild to moderate severity in an area with a high prevalence of penicillin resistance. Forty-nine patients were treated with 1.2·106 U of i.m. procaine penicillin every 12 h. By intent-to-treat analysis, 40 of 49 patients were cured and no patient died.Streptococcus pneumoniae could be demonstrated in 17 patients; 5 of 17 isolates were resistant to penicillin (MICs 0.25–4 μg/ml). Fifteen of 17 patients were cured with procaine penicillin, one presented allergy, and one was a therapeutic failure. Mean penicillin serum levels were 2.39±1.16 μg/ml (peak) and 0.61±0.38 μg/ml (trough). The results suggest that procaine penicillin may still be useful in the empirical therapy of suspected pneumococcal pneumonia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Appelbaum PC, Bhamjee A, Scragg JN, Hallett AF, Bowen AJ, Cooper CR:Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet (1977) ii:995–997.
Fenoll A, Martin-Bourgon C, Muñoz R, Vicioso D, Casal J: Serotype distribution and antimicrobial resistance ofStreptococcus pneumoniae isolates causing syste mic infection in Spain, 1979–1989. Reviews of Infectious Diseases (1991) 13:56–60.
Liñares J, Pallares R, Alonso T, Perez JL, Ayats J, Gudiol F, Viladrich PF, Martin R: Trends in antimicrobial resistance of clinical isolates ofStreptococcus pneumoniae in Bellvitge Hospital, Barcelona, Spain 1979–1990. Clinical Infectious Diseases (1992) 15:99–105.
Appelbaum PC: Antimicrobial resistance inStreptococcus pneumoniae: an overview. Clinical Infectious Diseases (1992) 15:77–83.
Friedland IR, McCracken GH Jr.: Management of infections caused by antibiotic-resistantStreptococcus pneumoniae. New England Journal of Medicine (1994) 331:377–382.
Pallares R, Gudiol F, Liñares J, Ariza J, Rufi G, Murgui L, Dorca J, Viladrich PF, Ariza J: Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. New England Journal of Medicine (1987) 317:18–22.
Musher DM:Streptococcus pneumoniae. In: Mandell GL, Bennett JE, Dolin R (eds): Principles and practice of infectious diseases. Churchill Livingstone, New York (1995) pp. 1811–1826.
Dorca J, Manresa F, Esteban LL, Barreiro B, Prats E, Ariza J, Verdaguer R, Gudiol F: Efficacy, safety and therapeutic relevance of transthoracic aspiration with ultrathin needle in non-ventilated nosocomial pneumonia. American Journal of Respiratory and Critical Care Medicine (1995) 151:1491–1496.
Chapin-Robertson K, Edberg SC: Measurements of antibiotics in human body fluids: techniques and significance. In: Lorian V (ed): Antibiotics in laboratory medicine. Williams & Wilkins, Baltimore (1991) pp. 295–366.
Griffin J: Serum inhibitory and bactericidal tilers. In: Isenberg HD (ed.): Clinical microbiology procedures handbook. American Society for Microbiology, Washington DC (1992) pp. 1–18.
Viladrich PF, Gudiol F, Liñares J, Rufi G, Ariza J, Pallares R: Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci. American Journal of Medicine (1988) 84:839–846.
Liñares J, Perez JL, Garau J, Murgui L, Martin R: Comparative susceptibilities of penicillin-resistant pneumococci to cotrimoxazole, vancomycin, rifampin, and fourteen beta-lactam antibiotics. Journal of Antimicrobial Chemotherapy (1984) 13:353–359.
Hackenbeck R, Tarpay M, Tomasz A: Multiple changes of penicillin-binding proteins in penicillin-resistant clinical isolates ofStreptococcus pneumoniae. Antimicrobial Agents and Chemotherapy (1980) 17:364–371.
Pallares R, Liñares J, Vadillo M, Cabellos C, Manresa F, Viladrich PF, Martin R, Gudiol F: Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. New England Journal of Medicine (1995) 333:474–480.
Muñoz R, Dowson DG, Daniels M, Coffey CJ, Martin C, Hakenbeck R, Spratt BG: Genetics of resistance to third-generation cephalosporins in clinical isolates ofStreptococcus pneumoniae. Molecular Microbiology (1992) 17:2461–2465.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cabellos, C., Ariza, J., Barreiro, B. et al. Current usefulness of procaine penicillin in the treatment of pneumococcal pneumonia. Eur. J. Clin. Microbiol. Infect. Dis. 17, 265–268 (1998). https://doi.org/10.1007/BF01699983
Issue Date:
DOI: https://doi.org/10.1007/BF01699983